GLABF
Gemina Laboratories Ltd.
Set alert
0.05 USD 0.00 0.00%
0.04 Day range 0.06
0.0375 52-week range 0.3439
- YTD
- 0.00%
- 1 year
- -85.46%
- Open
- 0.06
- Prev close
- 0.05
- Mkt cap
- 3.83M
- Vol
- 244.00K
- Avg vol
- 0
- EPS
- -0.03
- P/E
- 0.00
More statistics
- Low
- 0.04
- High
- 0.06
Financial health
Altman Z-Score
-29.17 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.2×
FY 2020 5y median -7.0× FY 2025
P/S 241×
FY 2020 5y median 0.0× FY 2025
P/B -0.9×
FY 2020 5y median -10.7× FY 2025
P/FCF -10.0×
FY 2020 5y median -10.0× FY 2025
EV/EBITDA -2.7×
FY 2020 5y median -7.1× FY 2025
EV/Sales 279×
FY 2020 5y median 0.0× FY 2025
FCF Yield -10.0%
FY 2020 5y median -10.0% FY 2025
Profitability
Gross Margin -74.4%
FY 2020 5y median 0.0% FY 2025
Operating Margin -10407.0%
FY 2020 5y median 0.0% FY 2025
Net Margin -10893.2%
FY 2020 5y median 0.0% FY 2025
ROE 39.2%
FY 2020 5y median 91.9% FY 2025
ROIC 47.8%
FY 2020 5y median 47.8% FY 2025
ROA -144.4%
FY 2020 5y median -318.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 42.8%
FY 2020 FY 2025
EPS (diluted) 44.2%
FY 2020 FY 2025
Free Cash Flow 60.1%
FY 2020 FY 2025
Financial Health
Current Ratio 0.1×
FY 2020 5y median 0.1× FY 2025
Quick Ratio 0.1×
FY 2020 5y median 0.1× FY 2025
Debt / Equity -0.2×
FY 2020 5y median -0.3× FY 2025
Net Debt / EBITDA -0.4×
FY 2020 5y median -0.1× FY 2025
Interest Coverage -32.1×
FY 2020 5y median -32.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2026-01-31